Evidence map›Paper›PMID 41327867›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Boron Nitride Nanomaterials Trigger Immunomodulatory Effects in Human Broncho-Epithelial Cells by Modulating Eicosanoid Lipid Signaling.

Govind Gupta, Jonas Bossart, Sènan Mickael D'Almeida, Luis Augusto Visani de Luna, Christoph Schwärzler, Tingting Fu, Vanesa Ayala-Nunez, Alexander Gogos, Marija Buljan, Vera M Kissling and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Govind GuptaSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0003-4703-418X
Jonas BossartSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0001-9004-3503
Sènan Mickael D'AlmeidaFlow Cytometry Core Facility, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
Luis Augusto Visani de LunaCentre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.ORCID https://orcid.org/0000-0003-0375-1064
Christoph SchwärzlerFlow Cytometry Core Facility, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
Tingting FuDepartment of Quantum Matter Physics, Laboratory of Advanced Technology, University of Geneva, 1211 Geneva 4, Geneva, 1205, Switzerland.
Vanesa Ayala-NunezSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0001-8401-8723
Alexander GogosSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.
Marija BuljanSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.
Vera M KisslingSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0002-4524-9905
Emmanuel FlahautCIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, Toulouse cedex 9, 31062, France.ORCID https://orcid.org/0000-0001-8344-6902
Miguel GarciaFlow Cytometry Core Facility, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
Cyrill BussyCentre for Nanotechnology in Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK.ORCID https://orcid.org/0000-0001-8870-443X
Peter WickSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0002-0079-4344
Tina Buerki-ThurnherrSwiss Federal Laboratories for Materials Science and Technology (Empa), Laboratory for Particles-Biology Interactions, St. Gallen, 9014, Switzerland.ORCID https://orcid.org/0000-0003-3723-6562

Funding

European Union's Horizon Europe research and innovation programme 101092686State Secretariat for Education, Research and Innovation (SERI) 00141
6 · The paper itself

Abstract

For the successful commercial development of emerging 2D materials, it is crucial to understand their potential biological effects on healthy and diseased individuals. The present study demonstrates that a repeated low-dose (1 µg cm

Indexed as

Boron CompoundsBronchiEicosanoidsEpithelial CellsLipid MetabolismNanostructuresAnimalsCells, CulturedHumansMiceSignal TransductionBoron Compoundsboron nitrideEicosanoidscytometry by time of flighteicosanoids signaling, grapheneinflammatory mediatorslipidomics

Identifiers

PMID41327867
PMCPMC12904077

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.